Patent · US Active

TYK2 inhibitors and uses thereof

US10570145B2 · kind B2 · utility

3Cited by
41References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 12, 2019
Grant dateFeb 25, 2020
Priority date
Expiry dateApr 28, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of TYK2, and the treatment of TYK2-mediated disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.